First IVF Success Rate: How Doctors Assess Individual Probability
In reproductive medicine clinics, when doctors evaluate a patient's "first IVF success rate," they do not provide a fixed number but rather make an individualized judgment based on multi-dimensional clinical evidence. This process involves a comprehensive analysis of ovarian reserve, sperm quality, embryo developmental potential, endometrial receptivity, and overall health status. The following explanation covers clinical data, age differences, key indicators, common misconceptions, and more.
Real Range of China's First IVF Success Rate
According to published clinical data from multiple domestic reproductive medicine centers and the annual report of the Chinese Society of Reproductive Medicine, the clinical pregnancy rate for the first IVF cycle (first egg retrieval cycle) in China shows the following distribution:
| Age Group | Clinical Pregnancy Rate (First Egg Retrieval Cycle) | Live Birth Rate (Estimated) |
|---|---|---|
| < 35 years | Approximately 50% – 60% | Approximately 42% – 52% |
| 35 – 37 years | Approximately 40% – 50% | Approximately 33% – 43% |
| 38 – 40 years | Approximately 30% – 40% | Approximately 22% – 32% |
| 41 – 42 years | Approximately 15% – 25% | Approximately 10% – 18% |
| > 42 years | Approximately 5% – 10% | Approximately 3% – 7% |
It should be clarified that the above data refers to the "clinical pregnancy rate," i.e., the proportion of gestational sacs observed by ultrasound after transfer. If calculated by the "live birth rate" (ultimately giving birth to a healthy baby), each age group would decrease by another 5–10 percentage points. Furthermore, these data come from aggregated statistics of different reproductive centers; success rates will vary for each specific center and individual.
Why There Is Such a Large Age Difference in First IVF Success Rate
Age is the most central factor affecting female fertility, driven by the simultaneous decline in oocyte quantity and quality.
- Oocyte Quantity: At birth, females have approximately 1–2 million oocytes, which decreases to 300,000–400,000 by puberty. After age 35, depletion accelerates, leaving about 10,000–20,000 by age 40. The reduction in ovarian reserve directly leads to fewer eggs retrieved and fewer available embryos.
- Oocyte Quality: More critically, the rate of chromosomal aneuploidy in oocytes increases significantly with age. Data shows:
Aneuploidy rate under 35: approximately 20%–30%;
35–37 years: approximately 30%–40%;
38–40 years: approximately 40%–50%;
41–42 years: approximately 50%–70%;
Over 42 years: exceeds 80%.
Chromosomal aneuploidy is the main cause of implantation failure, miscarriage, and birth defects. This is why, even with embryos, the probability of successful pregnancy after transfer decreases with age.
How Doctors Judge an Individual's First IVF Success Rate
When assessing individual success rates, reproductive specialists focus on the following indicators:
- Female Core Indicators: Age (primary independent factor), AMH (Anti-Müllerian Hormone, <1.1 ng/ml indicates diminished reserve), basal FSH (>10 IU/L suggests possible poor ovarian response), Antral Follicle Count AFC (total bilateral count <5–7 indicates reduced reserve), previous pregnancy history.
- Male Core Indicators: Semen analysis (concentration, motility, morphology), Sperm DNA Fragmentation Index DFI (>30% may affect embryo development and implantation).
- Embryo Factors: Fertilization rate (normal approximately 60%–80%), good-quality embryo rate (D3 approximately 40%–60%), blastocyst formation rate (approximately 40%–60%).
- Endometrial Factors: Endometrial thickness (<7 mm before transfer may affect implantation), endometrial pattern (triple-line pattern associated with higher pregnancy rate), endometrial blood flow (excessively high uterine artery blood flow resistance index may affect receptivity).
Differences in First IVF Strategies for Women of Different Ages
Under 35
Good ovarian reserve, higher rate of chromosomally normal embryos. Key strategies: Conventional ovarian stimulation protocols are sufficient; no need for excessive medication. Both fresh and frozen embryo transfers are viable. Single embryo transfer is recommended to reduce the risk of multiple pregnancies. The main concern is avoiding Ovarian Hyperstimulation Syndrome (OHSS).
35–37 Years
Ovarian reserve begins to decline, requiring strategy adjustments: Ovarian stimulation protocols need to be more individualized, possibly using antagonist or mild stimulation protocols. Blastocyst culture is recommended to improve single-transfer success rates through selection. If possible, consider Preimplantation Genetic Testing for Aneuploidy (PGT-A).
38–40 Years
Ovarian reserve is significantly reduced, and embryo aneuploidy rates are higher. Key strategies: Embryo accumulation strategy – may require multiple egg retrieval cycles to accumulate embryos. Blastocyst culture and PGT-A screening are strongly recommended. Pay attention to endometrial receptivity; consider Endometrial Receptivity Analysis (ERA) if necessary.
Over 40
Success rates are significantly lower, with clearer strategic goals: The primary goal is to accumulate usable embryos. Multiple egg retrievals may be necessary. PGT-A screening is strongly recommended. At the same time, be informed about egg donation options and prepare psychologically.
Easily Overlooked Details: Hidden Factors Affecting First IVF Success Rate
- Vitamin D Levels: Vitamin D deficiency is associated with reduced endometrial receptivity and lower embryo implantation rates. A high proportion of women of reproductive age in China have insufficient vitamin D; testing and supplementation before conception are recommended.
- Thyroid Function: TSH >2.5 mIU/L is associated with an increased miscarriage rate. Even if thyroid function is within the normal range, intervention is recommended if TSH exceeds 2.5.
- Homocysteine (Hcy): Elevated Hcy levels are linked to thrombosis and placental vascular dysfunction, potentially affecting embryo implantation and pregnancy maintenance.
- Sperm Epigenetics: Factors such as male age >40, smoking, obesity, and exposure to environmental toxins can cause epigenetic changes in sperm, affecting embryo developmental potential.
- Immune Factors: Abnormalities in NK cell activity, antiphospholipid antibodies, and thyroid autoantibodies may affect embryo implantation.
- Uterine Cavity Microenvironment: Chronic endometritis (CE) occurs in about 30% of infertile women, is difficult to detect with routine ultrasound, and requires hysteroscopy and endometrial biopsy for diagnosis.
Common Pitfalls: Misconceptions and Corrections
- Misconception 1: Failure in the first IVF cycle means there is no hope.
Fact: There are many reasons for first IVF failure, including embryonic chromosomal abnormalities (sporadic), poor endometrial receptivity, and timing of transfer. In most cases, the success rate of a second cycle improves after adjusting the protocol. - Misconception 2: The success rate is fixed.
Fact: The success rate is a population statistic; individual probability must be determined through comprehensive evaluation. Within the same reproductive center, success rates can vary dramatically between patients. - Misconception 3: Transferring more embryos increases the success rate.
Fact: Transferring multiple embryos does not proportionally increase the implantation rate and instead raises the risk of multiple pregnancies and miscarriage. The current mainstream trend in China is elective single embryo transfer. - Misconception 4: Blindly pursuing a high number of retrieved eggs.
Fact: A higher number of retrieved eggs is not necessarily better. When the number exceeds 15–20, egg quality may decline, and the risk of OHSS increases significantly. The goal should be to obtain a sufficient number of good-quality eggs, not the maximum number. - Misconception 5: Ignoring the male factor.
Fact: Approximately 30%–40% of infertility is related to male factors. Sperm DNA fragmentation rate and chromosomal abnormalities can affect embryo quality and implantation.
Key Examination Indicators: Understanding Your Fertility Report
| Indicator | Reference Range | Clinical Significance |
|---|---|---|
| AMH | >3.0 ng/ml Good 1.1–3.0 Normal <1.1 Diminished <0.5 Severely Diminished |
Reflects ovarian reserve; a reliable indicator of egg supply |
| Basal FSH (Day 2–3 of cycle) | <8 IU/L Normal 8–10 Borderline >10 Possible poor response |
Elevated FSH suggests diminished ovarian reserve; may result in fewer eggs retrieved during stimulation |
| Antral Follicle Count (AFC) | >10 (bilateral) Normal 5–10 Diminished <5 Severely Diminished |
Directly reflects the size of the basal follicle pool; positively correlated with number of eggs retrieved |
| Sperm DNA Fragmentation Index (DFI) | <15% Normal 15%–30% Moderate >30% High Fragmentation |
High DFI affects fertilization, embryo development, and implantation, increasing miscarriage risk |
Frequently Asked Questions
Q1: What is the national average first IVF success rate in China?
Currently, there is no officially published unified "first IVF success rate" data in China. Clinical pregnancy rates reported by different reproductive centers vary widely, from 40% to 65%. It is recommended to refer to the center's data from the past 1–2 years and distinguish between fresh and frozen embryo transfers, as well as blastocyst and cleavage-stage embryos.
Q2: If the first IVF cycle fails, will the second one be more successful?
Some studies show that after adjusting the ovarian stimulation protocol, optimizing embryo culture conditions, and improving endometrial receptivity, the success rate of a second cycle may be higher than the first. However, this depends on whether the cause of the first failure is clearly identified and specifically addressed.
Q3: Can PGT-A (third-generation IVF) improve the first success rate?
PGT-A can screen for chromosomally normal embryos for transfer, theoretically improving the implantation rate and clinical pregnancy rate per transfer while reducing the miscarriage rate. However, PGT-A cannot completely resolve issues like mosaicism or mitochondrial diseases, and there is a risk of embryo biopsy damage. It is suitable for women of advanced age, those with recurrent implantation failure, or recurrent miscarriage.
Q4: What happens to remaining embryos after a successful first IVF cycle?
Remaining embryos can be cryopreserved for future fertility plans. The survival rate of frozen embryos upon thawing is over 95%, and the pregnancy rate from frozen embryo transfer is comparable to that of fresh embryo transfer. The storage period is generally 5–10 years, requiring signed informed consent and payment of storage fees.
Q5: What preparations are needed before the first IVF cycle?
- Complete all pre-operative tests (including infectious diseases, chromosomes, endocrinology, etc.)
- Take folic acid supplements (for the woman, at least 1 month in advance)
- Adjust lifestyle: no smoking, no alcohol, regular routine, moderate exercise
- Control weight (BMI 18.5–24.9 kg/m²)
- Psychological preparation: understand the IVF process, timeline, costs, and potential risks
Female: AMH, basal FSH, LH, E2, antral follicle count, thyroid function, vitamin D level;
Male: Semen analysis, sperm DNA fragmentation index;
Both: Karyotype analysis, infectious disease screening.
Based on these results, the doctor can provide a success rate prediction closer to the individual's actual situation and offer targeted treatment strategies. IVF is a process requiring patience and a scientific approach. It is advisable to focus on the "cumulative live birth rate" as the goal, rather than fixating on the outcome of a single cycle.
Comments (0)